Study of Pioglitazone in Patients With Amyotrophic Lateral Sclerosis
Stopped The interim analysis showed no tendency in favour of the verum group. Therefore it was decided to stop the study prematurely.
Conditions
- Amyotrophic Lateral Sclerosis
Interventions
- DRUG: pioglitazone
- DRUG: placebo
Sponsor
University of Ulm